Normal view MARC view ISBD view

Challenges in the management of septic shock: a narrative review.

In Intensive Care Medicine.
By: De Backer D [Corresponding author].
Contributor(s): Cecconi M | Lipman J | Machado F | Myatra SN | Ostermann M | Perner A | Teboul JL | Vincent JL | Walley KR.
Material type: materialTypeLabelArticlePublisher: 2019Description: .Subject(s): Cardiac output | Fluids | Hemodynamic monitoring | Steroids | Tissue perfusion | Vasopressors In: Intensive Care Medicine Vol. 45, no. 4, p. 420-433.Summary: While guidelines provide important information on how to approach a patient in septic shock, "many challenges remain" for the management of these patients. In this narrative review, the panel discusses the challenges in identifying the right hemodynamic target, optimization of fluid therapy, selection of vasopressor agents, identification of patients who may benefit from inotropic agents or on the contrary beta-blockade, and use of steroids. The place for microcirculation-targeted therapy is debated as well as the use of alternative techniques (blood purification) and therapies (vitamin C). The implications of hemodynamic alterations on antibiotic doses is discussed. Finally, the specific challenges in low- and middle-income countries are addressed. Ongoing trials address some of these challenges, but many uncertainties will remain, and individualized therapies based on careful clinical assessment will continue to be essential to optimizing the care of patients with septic shock.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Articles Articles Tata Memorial Hospital
Available AR19357

Address for correspondence: ddebacke@ulb.ac.be.

While guidelines provide important information on how to approach a patient in septic shock, "many challenges remain" for the management of these patients. In this narrative review, the panel discusses the challenges in identifying the right hemodynamic target, optimization of fluid therapy, selection of vasopressor agents, identification of patients who may benefit from inotropic agents or on the contrary beta-blockade, and use of steroids. The place for microcirculation-targeted therapy is debated as well as the use of alternative techniques (blood purification) and therapies (vitamin C). The implications of hemodynamic alterations on antibiotic doses is discussed. Finally, the specific challenges in low- and middle-income countries are addressed. Ongoing trials address some of these challenges, but many uncertainties will remain, and individualized therapies based on careful clinical assessment will continue to be essential to optimizing the care of patients with septic shock.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha